1990
DOI: 10.1016/0002-9343(90)90299-s
|View full text |Cite
|
Sign up to set email alerts
|

Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reports

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
51
0
3

Year Published

2001
2001
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 130 publications
(55 citation statements)
references
References 90 publications
1
51
0
3
Order By: Relevance
“…Most recently, Morgenstern et al showed association between high doses of Ephedra in over-the-counter products for weight loss and energy enhancement and occurrence of hemorrhagic stroke 13 . Until 1992, 142 cases of hemorrhagic stroke associated to exposition to phenylpropanolamine as nasal decongestants have been reported 14 . Between 1969 and 1991, there were 22 spontaneous reports of such relation to the FDA.…”
Section: Discussionmentioning
confidence: 99%
“…Most recently, Morgenstern et al showed association between high doses of Ephedra in over-the-counter products for weight loss and energy enhancement and occurrence of hemorrhagic stroke 13 . Until 1992, 142 cases of hemorrhagic stroke associated to exposition to phenylpropanolamine as nasal decongestants have been reported 14 . Between 1969 and 1991, there were 22 spontaneous reports of such relation to the FDA.…”
Section: Discussionmentioning
confidence: 99%
“…Action is also seen at the beta receptor and in the CNS; the CNS stimulation is thought to be responsible for its anorectic effects leading to its use in diet pills [36]. Adverse effects of the medication include headache, tremor, insomnia, agitation, chest pain with significant toxicity producing palpitations, and severe hypertension [37]. Use of PPA has been associated with hemorrhagic strokes, cerebral vasculitis as well as infarctions; it is thought to be an independent risk factor for hemorrhagic stroke in women [36,38].…”
Section: Phenylpropanolaminementioning
confidence: 99%
“…LipoKinetix was marketed as a dietary supplement for weight loss. Hepatic injury appears to be due to an idiosyncratic reaction, perhaps related to phenylpropanolamine [14] . Among other weight loss agents, Usnic acid should be suspected in case of severe hepatotoxicity [15] .…”
Section: Discussionmentioning
confidence: 99%